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gras et al., 2001). By interfering with the function of mam-Nine Cambridge Center
malian TOR, rapamycin inhibits progression through theCambridge, Massachusetts 02142
G1 phase of the cell cycle in various cell types. Because2 Molecular Biology Program
of these antiproliferative effects, rapamycin is a clinicallyMemorial Sloan-Kettering Cancer Center
valuable drug that is currently used to block immune rejec-New York, New York 10021
tion of transplanted organs (Saunders et al., 2001) and in
trials for the treatment of cancer (Dudkin et al., 2001; Hi-
dalgo and Rowinsky, 2000) and for the prevention of reste-
nosis after angioplasty (Sousa et al., 2001).Summary
Mammalian TOR, mTOR (also known as RAFT1 or
FRAP), phosphorylates at least two regulators of proteinmTOR/RAFT1/FRAP is the target of the immunosup-
synthesis: S6K1 (formerly called p70 ribosomal S6 ki-pressive drug rapamycin and the central component of
nase) and an inhibitor of translation initiation, the eIF-a nutrient- and hormone-sensitive signaling pathway
4E binding protein 1 (4E-BP1) (Brunn et al., 1997; Burnettthat regulates cell growth. We report that mTOR forms
et al., 1998; Hara et al., 1997; Isotani et al., 1999). Ina stoichiometric complex with raptor, an evolutionarily
mammalian cells, amino acid deprivation leads to theconserved protein with at least two roles in the mTOR
dephosphorylation of both S6K1 and 4E-BP1 and topathway. Raptor has a positive role in nutrient-stimu-
decreased rates of protein synthesis, effects that arelated signaling to the downstream effector S6K1,
rapidly reversed by the readdition of amino acids (Fox etmaintenance of cell size, and mTOR protein expres-
al., 1998; Hara et al., 1998). Among amino acids, changes insion. The association of raptor with mTOR also nega-
leucine levels alone are sufficient to regulate the phos-tively regulates the mTOR kinase activity. Conditions
phorylation state and activity of both downstream com-that repress the pathway, such as nutrient deprivation
ponents of the mTOR pathway (Hara et al., 1998; Lynchand mitochondrial uncoupling, stabilize the mTOR-
et al., 2000). In addition to amino acid level in the media,raptor association and inhibit mTOR kinase activity.
mitochondrial function (Xu et al., 2001), glycolysis (Den-We propose that raptor is a missing component of
nis et al., 2001), and cell stress (Parrott and Templeton,the mTOR pathway that through its association with
1999) regulate S6K1, as do growth factors such as insu-mTOR regulates cell size in response to nutrient levels.
lin (Lawrence and Brunn, 2001).
Despite extensive efforts, how nutrients regulate theIntroduction
mTOR signaling pathway remains poorly understood. In
particular, stimuli that activate (e.g., amino acids) orIncreasing evidence indicates that in eukaryotes, cell
inhibit (e.g., mitochondrial uncouplers) downstream ef-growth (mass accumulation) is finely regulated in re-
fectors of mTOR, such as S6K1 and 4E-BP1, fail tosponse to environmental and developmental conditions
change the in vitro kinase activity of mTOR (Dennis etand can be deranged in human diseases such as cancer
al., 2001; Hara et al., 1997). This discrepancy has led us
and diabetes (reviewed by Dixon and Fordham-Skelton,
to hypothesize that in vivo mTOR exists as a complex
1998; Johnston and Gallant, 2002; Katso et al., 2001;
with one or more proteins that are lost during isolation
Kozma and Thomas, 2002; Schmelzle and Hall, 2000). of mTOR for in vitro assays. Several lines of evidence
The rate of mass accumulation is controlled not simply support the notion that mTOR associates with other
by the availability of nutrients, but by signaling pathways proteins: mTOR contains HEAT repeats, which are
that coordinate the activity of the cell growth machinery known to be protein-protein interaction motifs; it mi-
with nutritional, hormonal, and mitogenic signals. Stud- grates at a disproportionately large apparent molecular
ies into the mechanism of action of rapamycin, an immu- weight (1.5–2.0 mDa) in gel filtration chromatography
nosuppressive and anticancer drug, led to the discovery (D.M.S., unpublished data); and the expression in trans-
of an evolutionarily conserved regulator of cell growth, fected cells of mTOR fragments lacking the catalytic
the TOR (target of rapamycin) pathway (Brown et al., site has dominant-negative effects on the pathway (data
1994; Chiu et al., 1994; Kunz et al., 1993; Oldham et al., not shown). However, conventional biochemical at-
2000; Sabatini et al., 1994; Sabers et al., 1995; Zhang et tempts to purify mTOR-interacting proteins have been
al., 2000). The complex of rapamycin with its receptor, fruitless, as might be expected if mTOR-containing com-
FKBP12, binds directly to TOR and perturbs its function plexes were unstable under standard purification condi-
in a poorly understood fashion (Brown et al., 1995; Burnett tions. Therefore, we devised a purification scheme that
et al., 1998; Peterson et al., 2000; Zheng et al., 1995). uses a reversible chemical crosslinker to stabilize puta-
Studies in several organisms have shown that the TOR tive mTOR-containing complexes. Using this strategy,
we have discovered raptor (regulatory associated pro-
tein of mTOR), a protein that we find has a positive role3 Correspondence: sabatini@wi.mit.edu
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Figure 1. Identification of a 150 kDa mTOR-Associated Protein
(A) Autoradiograph of SDS-PAGE analysis of mTOR immunoprecipitates prepared from metabolically labeled HEK293T cells lysed in the
absence () or presence () of the chemical crosslinker DSP, or from lysates treated with DSP 30 min after lysis (30). The 150 kDa protein
is not coimmunoprecipitated by antibodies recognizing the EGF receptor (EGFR), the 110 kDa subunit of PI-3-kinase (PI3K p110), the ribosomal
S6 kinase (S6K1), actin, or lamin.
(B) Silver stain of SDS-PAGE analysis of mTOR immunoprecipitates isolated as in (A) from unlabeled cells. Quantitation reveals a ratio of 1.0
mTOR to 0.84 p150.
(C) Autoradiograph of SDS-PAGE analysis of mTOR immunoprecipitates prepared from cells metabolically labeled to equilibrium. Quantitation
reveals a ratio of 0.92 mTOR to 1.0 p150 after normalization to the methionine content of each protein.
in nutrient signaling to S6K1 and in the control of cell (SVSSYGNIR, LDDQIFLNR, and IPEEHDLESQIR), all of
size. The mTOR-raptor interaction also regulates the which are contained within KIAA1303 (NCBI # 7242961),
kinase activity of mTOR and is sensitive to conditions, a partial ORF for a human protein of unknown function.
such as nutrient availability, that signal through the path- Using the BLAST homology search algorithm, we found
way. Thus, we provide a mechanism for how nutrients that KIAA1303 likely represents an N-terminally trun-
regulate mTOR activity in vivo. Although rapamycin has cated fragment of the human homolog of fission yeast
been regarded as mimicking the effects of nutrient depri- Mip1p. The function of Mip1 is not clear, but, interest-
vation, we find that the two conditions have opposite ingly, it has been implicated in cell growth and nitrogen
effects on the mTOR-raptor interaction. sensing (Shinozaki-Yabana et al., 2000), processes reg-
ulated by TOR proteins in a variety of organisms. By
Results searching EST databases, we identified overlapping
cDNAs that extended the 5 end of the KIAA1303 cDNA
Identification of Raptor as an and provided sequence information that allowed us to
mTOR-Associated Protein design PCR primers and assemble a full-length cDNA
HEK293T cells were metabolically labeled with for human raptor. The 7051 nucleotide mRNA contains
[35S]methionine and lysed in the presence or absence an open reading frame encoding a protein of 1335 amino
of the reversible crosslinker dithiobis(succinimidylpropi- acids (predicted molecular weight of 149 kDa) that is
onate) (DSP). mTOR immunoprecipitates prepared from flanked by 5 and 3 untranslated regions of 0.9 and 2.1
these lysates were then treated with dithiothreitol to kb, respectively. Human genome sequence information
reduce the DSP crosslinks and analyzed by SDS-PAGE for the raptor locus is still incomplete but permitted us
and autoradiography. A protein with an apparent molec- to localize the gene to human chromosome 17q25.3.
ular weight of 150 kDa coprecipitated with mTOR only
Raptor shows a high degree of conservation amongst
in immunoprecipitates recovered from lysates prepared
all eukaryotes with completed genome projects, includ-in the presence of DSP (Figure 1A). The intensity of this
ing D. melanogaster, S. pombe, S. cerevisiae, C. ele-band decreased significantly when DSP was added 30
gans, and A. thaliana (Figure 2A and see Supplementalmin after cell lysis, suggesting that the protein interacts
Figure S1 at http://www.cell.com/cgi/content/full/110/weakly or transiently with mTOR or that the lysis proce-
2/163/DC1). The raptor homologs in budding (Winzelerdure disrupts the association (Figure 1A). For reasons
et al., 1999) and fission (Shinozaki-Yabana et al., 2000)that will become apparent, we have named the 150 kDa
yeasts are encoded by essential genes. All raptor homo-protein raptor (regulatory associated protein of mTOR).
logs have a novel N-terminal domain that we haveRaptor was also detected in silver- (Figure 1B) or Coo-
named RNC (for raptor N-terminal conserved) that con-massie blue-stained gels (data not shown) of mTOR
sists of three blocks with at least 67%–79% sequenceimmunoprecipitates prepared from DSP-treated lysates
similarity (Figure 2B). The RNC domain is unrelated toof unlabeled cells. Quantitation of the amount of raptor
other sequences in the public databases and is pre-isolated with mTOR indicates that it is present in near
dicted to have a high propensity to form  helixes. Fol-stoichiometric amounts with mTOR (Figures 1B and 1C).
lowing the RNC domain, all raptor homologs have three
HEAT repeats (Andrade and Bork, 1995), which are thenRaptor Is an Evolutionarily Conserved Protein
followed by seven WD40 repeats in the C-terminal thirdwith a Novel N-Terminal Domain and Seven
of the protein (Figure 2A). Northern blot analysis showsWD40 Repeats
that raptor is expressed in all human tissues in a patternTo characterize raptor, we obtained sequence informa-
tion by mass spectrometry and identified three peptides similar to that of mTOR, with the greatest levels of both
Raptor Forms a Nutrient-Sensitive Complex with mTOR
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Figure 2. Raptor Is an Evolutionarily Conserved Protein and Is Widely Expressed in Human Tissues in a Similar Pattern to mTOR
(A) Schematic representation of structural features of raptor and its homologs. The seventh WD40 repeat of C. elegans raptor is indicated
with an empty green box because it lacks the prototypical Trp/Asp pattern. The accession numbers for the raptor homologs are: D. melanogaster
(AAF46122), S. pombe (P87141), S. cerevisiae (P38873), C. elegans (T19183), and A. thaliana (NP_187497).
(B) Amino acid sequence alignment of the RNC domains from the species in (A) shows identical (asterisk), conserved (double dot), and partially
conserved (single dot) residues. Amino acid characteristics are depicted with a ClustalX color scheme (Thompson et al., 1997).
(C) Northern blot analysis of a multiple human tissue blot (Clontech) for raptor, mTOR, and -actin.
mRNAs found in skeletal muscle, brain, kidney, and pla- coprecipitating raptor obtained at 0.3% CHAPS. Inter-
centa (Figure 2C). estingly, the majority of in vitro studies on mTOR func-
tion have been performed on mTOR isolated from cells
lysed with Triton X-100 or the related detergent NP-40,Specific mTOR-Raptor Interaction In Vivo
conditions that we find completely disassociate raptorTo characterize the mTOR-raptor interaction, we gener-
from mTOR. Unless otherwise stated, further experi-ated a polyclonal antibody that specifically recognizes
ments were performed using a lysis buffer (Buffer B, seeamino acids 985 to 1001 of human raptor. This antibody
Experimental Procedures) that allowed the recovery ofdetected raptor in immunoprecipitates prepared from
a complex containing a ratio of about 1.0 mTOR to 0.7DSP-treated cell lysates using two different anti-mTOR
raptor (data not shown). In addition to HEK293T cells,antibodies but not in immunoprecipitates obtained with
the mTOR-raptor complex was detected in all other hu-control antibodies (Figure 3A). To enable a study of the
man cell lines tested, including the uterine cancer HeLa-,physiological regulation of the mTOR-raptor interaction,
B cell lymphoma BJAB-, neuroblastoma SK-N-MC-, andwe searched for lysis conditions that might preserve the
lung cancer A549-derived cell lines (Figure 3C), sug-complex in the absence of the chemical crosslinker. We
gesting that the association likely occurs in most cellachieved this by avoiding lysis buffers with Triton X-100,
types. In transfected HEK293T cells, we also detecteda detergent that eliminated the interaction at all concen-
the interaction of epitope-tagged raptor with endoge-trations tested (Figure 3B). Lysis of cells in buffers con-
nous mTOR (Figure 3D) as well as between epitope-taining the detergent CHAPS instead of Triton X-100
preserved the interaction with the greatest amount of tagged versions of both proteins (Figure 3E).
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Figure 3. In Vivo Interactions between Endogenous Raptor and Figure 4. Protein Domains Involved in the mTOR-Raptor Interaction
mTOR and Recombinant Versions of Both Proteins
(A) Myc-tagged mTOR, its indicated fragments, or -tubulin were
(A) Levels of raptor and mTOR in immunoprecipitates prepared with coexpressed in HEK293T cells with HA-raptor (bottom), and anti-
indicated antibodies. The mTOR Ab1 and Ab2 antibodies recognize myc immunoprecipitates were analyzed by anti-HA (top) and anti-
residues 1–18 and 221–237, respectively, of human mTOR. myc (middle) immunoblotting.
(B) Levels of raptor and mTOR in mTOR immunoprecipitates from (B) Immunoblot analysis shows levels of mTOR (top) in anti-HA
cells lysed in buffers with the indicated concentrations of Triton immunoprecipitates prepared from HEK293T cells transfected with
X-100 or CHAPS. 1 g of plasmids encoding HA-tagged raptor, its fragments, or the
(C) mTOR immunoprecipitates prepared from lysates (1 mg total mutants shown in the schematic. Anti-HA immunoblot shows levels
protein) of indicated cell types were analyzed as in (B). of full-length raptor or fragments in the immunoprecipitates
(D) Endogenous mTOR (top) interacts with recombinant raptor but (bottom).
not tubulin (bottom). Anti-myc immunoprecipitates were prepared
from HEK293T cells transfected with 100 ng of either a myc-raptor-
or a myc--tubulin-encoding plasmid.
(E) Recombinant mTOR and raptor interact in transfected HEK293T of the N-terminal region of mTOR by 297 residues se-
cells. Shown are levels of HA-raptor (top) and myc-mTOR and myc- verely weakened the interaction, and fragments of the
-tubulin (middle) in anti-myc immunoprecipitates prepared from N-terminal region of mTOR (amino acids 21–551 or 652–
HEK293T cells transfected with 100 ng of a plasmid encoding HA-
1185) were incapable of interacting with raptor. Theseraptor and 100 ng of one encoding either myc-mTOR or myc--
results suggest that the overall structure of the N-ter-tubulin.
minal portion of mTOR is required for the association
with raptor and that the C-terminal half of mTOR con-
tains a weaker interaction site.The mTOR-Raptor Interaction Requires the mTOR
HEAT Repeats and Multiple Sites on Raptor None of the individual domains of recombinant HA-
tagged raptor expressed in HEK293T cells could interactTo identify which region(s) of mTOR interacts with rap-
tor, we expressed in HEK293T cells several myc-tagged with the endogenous mTOR (Figure 4B). Several muta-
tions in the RNC or WD40 domains of raptor, generatedmTOR fragments together with the full-length HA-
tagged raptor protein. The N-terminal region of mTOR by changing evolutionarily conserved residues, elimi-
nated the interaction with mTOR, whereas another RNC(amino acids 1–1482) containing all the HEAT motifs
interacted with raptor almost as strongly as the full- domain mutation (mut 4), as well as a mutation in the
region between the HEAT and WD40 repeats (mut 7),length protein, whereas the C-terminal region (amino
acids 1348–2549) exhibited a weak but greater than did not affect it. These observations indicate that the
mTOR-raptor interaction may involve multiple sites inbackground interaction (Figure 4A). Further shortening
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raptor and a large region of mTOR and suggest that cells transfected with siRNAs targeting raptor or mTOR
underwent comparable reductions in size and that thesethe proteins make extensive contacts with each other.
Alternatively, the mutations in raptor may destabilize its correlated with a decrease in the phosphorylation state
of S6K1 (Figure 5C). The siRNA-mediated reductions inentire structure and disturb the mTOR-raptor associa-
tion without directly being part of the mTOR interaction cell size are significant (p  0.001) but less than the
reduction caused by treatment of cells with rapamycinsite. Interestingly, ATR, a protein which like mTOR is a
member of the PIK-related family of kinases, makes for 48 hr. This is expected because rapamycin com-
pletely inhibits S6K1 phosphorylation in all of the cells,extensive contacts with ATRIP (ATR-interacting pro-
tein), a recently discovered interacting partner of ATR while the raptor and mTOR siRNAs partially inhibit S6K1
only in the transfected cells.(Cortez et al., 2001).
Raptor Participates in Nutrient Signaling
Raptor Participates in Regulating Cell Sizeand Maintenance of Cell Size
HEK293T cells grown to confluence in a tissue cultureA major role of the mTOR pathway is to coordinate
dish become smaller than actively growing cells and,the synthesis of ribosomal proteins with the levels of
after dilution and plating into fresh media, regain theiravailable amino acids. This is accomplished by control-
normal mean size over a period of 3 days (D.-H.K. andling the translational regulator S6K1, a kinase whose
D.M.S., unpublished data). As cells transfected with thephosphorylation state and in vivo activity are regulated
lamin siRNA emerged from confluence, they graduallyby amino acid levels (Fox et al., 1998; Hara et al., 1998)
increased in mean size over a period of 3 days, an effectand is phosphorylated in vitro by mTOR (Burnett et al.,
that was inhibited in the cells transfected with the mTOR1998; Isotani et al., 1999). To investigate the role of raptor
or raptor siRNAs and dramatically reduced by rapa-in mTOR-mediated signaling, we used small interfering
mycin (Figure 5D).RNA (siRNA) (Elbashir et al., 2001) to decrease endoge-
We also examined the effects of reducing raptor andnous levels of raptor in HEK293T cells and measured the
mTOR levels on the capacity of cells, in the absence ofphosphorylation state of S6K1 in response to stimulation
proliferation, to increase in size after a reduction in sizewith increasing concentrations of leucine. Consistent
caused by prolonged nutrient deprivation. Cells werewith a critical role for raptor in nutrient signaling to S6K1,
transfected with siRNAs targeting lamin, mTOR, or rap-a decreased level of raptor attenuated leucine-stimu-
tor and, 24 hr after transfection, cells were incubated inlated phosphorylation of S6K1 to a similar extent as a
leucine-free media for an additional 24 hr. During thisdecreased level of mTOR achieved with an siRNA spe-
period of leucine deprivation, the cells ceased to dividecific to mTOR (Figures 5A and 5B). Reductions in the
and became extremely small so that, irrespective oflevels of raptor or mTOR did not significantly affect the
transfected siRNA, the mean cell volume in all the sam-amounts of S6K1 and ATM, or the phosphorylation state
ples was about 67% of the mean volume of cells inor amount of PKB/Akt, a downstream effector of PI
leucine-containing media (Figure 5E). Leucine was then3-Kinase. Interestingly, mTOR and raptor expression ap-
added to the media and cell size measured at 6 and 10pear to be coordinately regulated because reduced lev-
hr after leucine addition. The growth of cells transfectedels of either protein induced by its specific siRNA also
with the mTOR or raptor siRNAs or treated with rapa-decreased the level of the other without affecting the
mycin at the time of leucine addition was impaired asamount of its mRNA (data not shown). The inhibitory
these cells increased in size significantly less than thoseeffect on S6K1 signaling of the raptor-targeted siRNA
transfected with the lamin siRNA. During this period ofis not simply due to its decrease of mTOR levels. In
growth, the cells did not divide and resumption of cellcontrol experiments using the mTOR-targeted siRNA,
proliferation did not begin until 15–20 hr after leucinewe found that to observe any effect on S6K1 phosphory-
addition (data not shown).lation, mTOR had to be reduced to less than 25% its
As described above, reductions in raptor and mTORnormal level (data not shown), a far higher reduction
protein levels have similar effects on nutrient-stimulatedthan caused by the raptor-targeted siRNA (Figure 5B).
increases in S6K1 phosphorylation and cell size and onThe mutual dependence of expression we observed be-
the maintenance of cell size. In addition, we find thattween mTOR and raptor is another similarity the partners
mTOR and raptor exist in a near stoichiometric complexshare with the ATR-ATRIP interacting pair (Cortez et al.,
(Figure 1). A parsimonious explanation for these findings2001).
is that raptor and mTOR are part of the same signalingIn Drosophila, the TOR pathway is a major regulator
system that regulates S6K1 phosphorylation. If this wereof cell growth and, thus, cell size (Oldham et al., 2000;
not the case, we would expect that reducing both raptorZhang et al., 2000). A large part of this regulation is
and mTOR levels in the same cells would have additiveexerted through S6K1, and, in Drosophila and mice, loss
inhibitory effects on the nutrient-stimulated S6K1 phos-of function mutations in S6K1 lead to smaller animals
phorylation because two independent pathways wouldwith smaller cells (Montagne et al., 1999; Shima et al.,
be affected. However, we find that in cells cotransfected1998). A role for mTOR in regulating cell size can also
with siRNAs targeting both raptor and mTOR, S6K1be demonstrated in tissue culture, as inhibition of the
phosphorylation is reduced to a similar extent as in cellspathway with rapamycin treatment reduces the size of
transfected with either siRNA alone (see Supplementalmany mammalian cell types, including HEK293Ts, dur-
Figure S2 at http://www.cell.com/cgi/content/full/110/ing all phases of the cell cycle (S.M.A. and D.M.S., un-
2/163/DC1), supporting our suggestion that mTOR andpublished data and Figure 5C). Consistent with a role
for raptor in size control, we found that actively dividing raptor are part of the same pathway.
Cell
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Figure 5. Raptor Participates in Nutrient Signaling to S6K1 and Maintenance and Regulation of Cell Size
(A) HEK293T cells transfected with indicated siRNAs and deprived of leucine for 50 min were stimulated for 10 min with increasing amounts
of leucine (0, 5.2, 16, and 52 g/ml), and lysates (20 g protein) were analyzed by immunoblotting for indicated proteins and phosphorylation
states.
(B) Graph of means 	 SD (n 
 3) for S6K1 phosphorylation level from experiments performed as in (A) and quantitated by densitometry. Table
of means 	 SD (n 
 4) of levels of indicated proteins determined by densitometry of immunoblots in (A).
(C) Cells transfected with siRNAs were analyzed by immunoblotting for indicated proteins, and cell diameters and volumes were determined
3 days after transfection. Shown are size distributions of nontransfected cells (black line) and of cells transfected with the indicated siRNAs
or treated with 20 nM rapamycin for 48 hr (red lines). The mean 	 SD cell diameters (m) and volumes (pL) are, respectively: nontransfected
cells, 15.92 	 0.11 and 2111 	 44 (n 
 5); lamin siRNA, 15.89 	 0.10 and 2099 	 39 (n 
 5); mTOR siRNA, 15.43 	 0.09 and 1922 	 33 (n 

6); raptor siRNA, 15.45 	 0.07 and 1930 	 26 (n 
 6); and rapamycin-treated cells, 14.61 	 0.10 and 1632 	 33 (n 
 5). A least 10,000 cells
were analyzed per trial.
(D) Cells transfected with the indicated siRNAs were grown to confluence and induced into active growth by dilution into fresh media, and
cell volumes were determined at 1, 2, and 3 days after dilution (n
 3). For comparison, nontransfected cells were treated with 20 nM rapamycin
at 1 day after dilution. Size reductions caused by raptor and mTOR siRNAs are significant to p  0.01 and 0.05 at the 2 and 3 day time points,
respectively.
(E) Cells were transfected with the indicated siRNAs and manipulated as described in the text (n 
 3). Size reductions caused by the raptor
and mTOR siRNAs and by rapamycin at 10 hr are significant to p  0.05.
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Nutrients and Mitochondrial Function Regulate activity. In addition to nutrients and cell stress, growth
the Stability of the mTOR-Raptor Complex factors such as insulin are also known to regulate down-
and the mTOR Kinase Activity stream components of the mTOR pathway, like S6K1
To determine if the mTOR-raptor interaction is regulated (Lawrence and Brunn, 2001). However, we found that
by conditions that are known to affect the activity of while treatment of serum-starved cells with insulin in-
downstream effectors of mTOR, we tested the effects creased the phosphorylation state of S6K1, it did not
of different nutrient conditions on the stability of the affect the raptor-mTOR interaction (see Supplemental
mTOR-raptor complex. The amount of raptor recovered Figure S3 at http://www.cell.com/cgi/content/full/110/
bound to mTOR was markedly increased when HEK293T 2/163/DC1), suggesting that its regulation might be inde-
cells were incubated in amino acid-deprived medium, pendent of growth factor signaling. Furthermore, in se-
an effect that was mimicked by the removal of just leu- rum-starved cells, the mTOR-raptor interaction was still
cine from the culture medium (Figures 6A and 6B). Im- regulated by nutrients (data not shown).
portantly, a 10 min stimulation with leucine, which acti-
vates the phosphorylation of S6K1 and 4E-BP1 (Figures Increasing the Amount of Raptor Bound to mTOR
5, 6A, and 6B), reversed the effect of leucine deprivation Leads to an Inhibition of the mTOR
and restored the interaction to the level observed in Kinase Activity
cells grown in nutrient-rich medium. Furthermore, the The inverse correlation we observed between the stabil-
in vitro kinase activity of mTOR toward S6K1 and 4E-BP1 ity of the mTOR-raptor interaction and the kinase activity
inversely correlated with the amount of raptor recovered of mTOR suggests that a strong association between
with mTOR. Greater activity was observed in raptor- raptor and mTOR leads to an inhibition of the mTOR
deprived complexes obtained after nutrient stimulation. catalytic activity. To substantiate this correlation, we
Conversely, reduced activity was observed in raptor- compared the activity of mTOR isolated under cell lysis
enriched complexes obtained after nutrient starvation conditions that differentially affect the mTOR-raptor as-
(Figures 6A and 6B). We also found that glucose depriva- sociation (see Supplemental Figure S4). A small increase
tion and readdition affected the mTOR-raptor interac- in salt concentration in the lysis buffer slightly reduced
tion and mTOR activity in a similar fashion, as did the amount of raptor bound to mTOR, and this correlated
changes in leucine levels. with a corresponding increase in mTOR activity. Strik-
Although we used a mild buffer to prepare the mTOR ingly, the addition of Triton X-100 to the lysis buffer
immunoprecipitates (in order to preserve the raptor- eliminated the interaction and also strongly activated in
mTOR association), control kinase assays confirm that vitro mTOR activity.
the observed activity is that of mTOR and not of a con- To exclude the possibility that the different isolation
taminating kinase that also might be capable of phos- conditions directly affect mTOR activity, we determined
phorylating S6K1 (Figure 6C). The kinase activity in the whether an increase in the intracellular concentration of
mTOR immunoprecipitates depends on the presence of raptor could drive, even in cells growing in nutrient-
mTOR and is sensitive to LY294002, a known inhibitor rich conditions, the formation of stable mTOR-raptor
of mTOR (Brunn et al., 1996), but not to high concentra- complexes and inhibit mTOR kinase activity. Overex-
tions of other kinase inhibitors. Moreover, the kinase pression of wild-type raptor, but not of a mutant that
activity of recombinant mTOR isolated under the same cannot interact with mTOR (mut 1 in Figure 4), resulted
conditions depends on a wild-type mTOR kinase domain in an increased amount of raptor bound to mTOR and
and is sensitive to LY294002. Thus, these findings sup- a decrease in its in vitro kinase activity (Figure 6E). In
port the conclusion that, when mTOR is isolated under
addition, the overexpression of wild-type but not mutant
conditions designed to preserve its interaction with rap-
raptor decreased the in vivo phosphorylation state of
tor, the activity of the isolated kinase does change in
S6K1 and increased the amount of 4E-BP1 bound toconcert with the in vivo effects of stimuli that regulate
eIF-4E (Figures 6E and 6F), providing in vivo correlatesthe pathway.
of the inhibitory effects of raptor on the in vitro mTORThe identity of the intracellular messengers that signal
kinase activity. These results strongly indicate that anutrient availability to mTOR is unknown, but several
tightly bound raptor leads to a decrease in mTOR kinaselines of evidence suggest that the mitochondrial metab-
activity and that raptor overexpression can circumventolism of nutrients is necessary to activate the pathway
the normal nutrient-regulated mechanism(s) that control(Dennis et al., 2001; Xu et al., 2001; D.D.S., D.-H.K., and
the strength of the interaction.D.M.S., unpublished data). We found that valinomycin,
a mitochondrial uncoupler (Bernard and Cockrell, 1979),
Evidence that the mTOR-Raptor Complex Existsantimycin A, an electron transport inhibitor (Wolvetang
in Two Binding Stateset al., 1994), and 2-deoxyglucose, a glycolytic inhibitor,
Despite the negative role of raptor in regulating thestabilized the mTOR-raptor interaction and inhibited
mTOR kinase activity, the experiments using siRNA indi-mTOR kinase activity in a fashion similar to nutrient
cate that in vivo raptor also has a positive function indeprivation (Figure 6D). Other cell-stressing conditions
the mTOR pathway as decreased levels of raptor reduceknown to inhibit S6K1 in vivo, such as the oxidative
S6K1 phosphorylation, cell size, rate of cell growth, andstress caused by H2O2 treatment, which affects mito-
mTOR expression (Figure 5). Moreover, when a cross-chondrial function (Majumder et al., 2001), also stabi-
linker was present during the cell lysis, raptor was iso-lized the interaction and inhibited the mTOR kinase.
lated in a stoichiometric complex with mTOR (Figure 1).On the other hand, a sucrose-induced osmotic shock
Thus, it seemed unlikely that the decreased amount ofdecreased the phosphorylation state of S6K1 but had
only a modest effect on complex stability and kinase raptor recovered with mTOR isolated from cells grown
Cell
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Figure 6. Nutrients, Mitochondrial Function, and Glycolysis Regulate the mTOR-Raptor Interaction and mTOR Kinase Activity
(A) HEK293T cells were not treated (control), deprived of the indicated nutrients for 50 min, or deprived for 50 min and restimulated for 10
min with 52 g/ml leucine (leu  leu) or 11 mM glucose (gluc  gluc). mTOR kinase activity toward GST-S6K1 was determined in anti-
mTOR immunoprecipitates (third gel from top). Immunoblots show levels of mTOR and raptor in the kinase reactions and the phosphorylation
state and gel mobility of S6K1 (bottom two gels).
(B) Experiment was performed as in (A) except that 4E-BP1 was used a substrate.
(C) The kinase activity in anti-mTOR immunoprecipitates depends on the presence of mTOR and is sensitive to 20 M LY294002 (LY) but not
to 40 nM protein kinase A inhibitor (PKI), 20 M H-8 (an inhibitor of PKA, PKG, and PKC), and 20 M PD98059 (PD) (an inhibitor of MEK). The
activity of recombinant, myc-tagged mTOR (wt) is absent in the D2357E mutant (kd) and sensitive to 20 M LY (bottom gels).
(D) Cells treated for 10 min with 500 mM sucrose, 1 mM H202, 1 M valinomycin, 5 M antimycin A, or 100 mM 2-deoxyglucose (2-DG) or not
treated (control) were analyzed as in (A).
(E) HEK293T cells transfected with 5 g of the mammalian expression vector prk5 (empty), the vector encoding raptor (raptor wt), or a mutant
incapable of interacting with mTOR (raptor mut 1) were analyzed as in (A).
(F) Experiments were performed as in (E) except that cells were transfected with 50 ng of a plasmid encoding myc-4E-BP1. 7-methyl-GTP
affinity chromatography and eIF-4E Western blotting were performed as described (Burnett et al., 1998).
in nutrient-rich conditions (Figures 6A and 6B) reflects These findings show that in vivo raptor and mTOR
physically interact under both leucine-rich and -poora dissociation of the mTOR-raptor complexes in vivo.
This was proven to be the case, as the amounts of raptor conditions and suggest that mTOR-raptor complexes
exist in at least two nutrient-determined states with dif-recovered with mTOR isolated from leucine-deprived
or -stimulated cells were similar when cells were lysed ferential stability: an unstable complex that does not
survive in vitro isolation and a stable complex that does.in the presence of the crosslinker (Figure 7A).
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absence of a crosslinker (Figure 7B), the interaction of
mut 4 was not sensitive to leucine levels, while that of mut
7 was still regulated (Figure 7C). These findings indicate
that mutants 5 and 4 form complexes similar to those
found under nutrient-rich and -poor conditions, respec-
tively. Complexes containing mutant 5 are in the unsta-
ble state characteristic of nutrient-rich conditions, while
those containing mutant 4 are in the stable state found
under nutrient-poor conditions.
Rapamycin Severely Weakens the
mTOR-Raptor Interaction
In vivo, rapamycin, like nutrient deprivation, inhibits the
activation of downstream effectors of mTOR, but exactly
how the drug perturbs mTOR function is unknown. We
found that treatment of HEK293T cells with rapamycin
or the addition of the drug to cell lysates significantly
destabilized the mTOR-raptor complex (Figure 8A). The
effect was specific to rapamycin, as FK506, an immuno-
suppressant that also binds FKBP12 but does not target
mTOR, had no effect on the interaction, nor did ethanol,
the vehicle used for both drugs. However, when lysates
were prepared in the presence of the crosslinker DSP,
almost normal levels of raptor were recovered with
mTOR. Therefore, as with nutrient stimulation and raptor
mutant 5, rapamycin destabilizes the raptor-mTOR com-
plex but does not abolish it in vivo.
We also examined the effect of increasing concentra-
tions of rapamycin on the mTOR-raptor interaction inFigure 7. The mTOR-Raptor Complex Exists in Two Binding States
cells deprived of or stimulated with leucine. Interest-(A) Raptor amounts in mTOR immunoprecipitates prepared from
ingly, irrespective of nutrient conditions, rapamycincells grown in leucine-rich or -poor conditions and lysed in the
presence of DSP. dominantly destabilized the raptor-mTOR complex, and
(B) Raptor mutant 5 forms an unstable complex with mTOR. mTOR the order of rapamycin addition and leucine deprivation
immunoprecipitates were prepared from cells transfected with 10 did not matter (Figure 8B). In addition, leucine-rich con-
ng of the indicated raptor plasmids and lysed in the absence or
ditions enhanced the destabilizing effects of rapamycin,presence of DSP. Immunoblots show amounts of mTOR and indi-
decreasing its EC50 for mTOR-raptor dissociation bycated HA-raptors in mTOR immunoprecipitates and expression lev-
about 3-fold (from 5 nM to 1.5 nM) when compared toels of the raptor mutants.
(C) The interactions of raptor mutant 4 with mTOR is not regulated leucine-poor conditions. A simple explanation for this
by nutrients. HEK293T cells transfected with 10 ng of the indicated latter result might be that leucine-poor conditions lead
raptor plasmids were incubated for 50 min in leucine-free () or to a decrease in the affinity between mTOR and FKBP12-
-rich () media, and amounts of mTOR and HA-raptor in the mTOR
rapamycin, perhaps by inducing a conformationalimmunoprecipitates were analyzed as in (B) (short exp). Leucine
change in the FKBP12-rapamycin binding site in mTOR.levels do not regulate the residual interaction between raptor mutant
Alternatively, leucine deprivation might increase the af-5 and mTOR (long exp).
finity between raptor and mTOR so that the complex is
less susceptible to the destabilizing effects of FKBP12-
rapamycin. The finding that the unstable and stableAs nutrient-rich conditions decreased the amount of
complexes found in nutrient-rich and -poor conditions,raptor recovered with mTOR, it is likely that nutrients
respectively, are differentially sensitive to rapamycinlead to the formation of the unstable complex. We
provides further evidence that the raptor-mTOR com-sought evidence for these two binding states by asking
plex can exist in two binding states.if any of the raptor mutants we identified formed com-
plexes with mTOR that were permanently in the unstable
or stable state. We searched for a mutant that forms an Discussion
unstable complex with mTOR by screening the mutants
for those that are recovered with mTOR only when cells Raptor Forms a Nutrient-Sensitive Complex (NSC)
with mTORare lysed in the presence of a crosslinker (Figure 7B).
Only one mutant (mut 5) had this characteristic, indicat- We have identified raptor, a 149 kDa protein that partici-
pates in the mTOR pathway and associates in a nearing that in vivo mut 5 does associate with mTOR but
that the interaction does not survive the in vitro isolation stoichiometric ratio with mTOR to form a nutrient-sensi-
tive complex (NSC). Raptor and mTOR associate underconditions. As expected, the small residual interaction
of mut 5 with mTOR was no longer sensitive to levels all nutrient conditions, but the stability of the complex
changes with the activity of the pathway. Under nutrient-of leucine in the media (Figure 7C). Next, we searched
for a mutant that forms a stable complex with mTOR poor conditions, the mTOR-raptor association is stabi-
lized and high levels of the complexes are recoveredirrespective of nutrient conditions. Of the two raptor
mutants (muts 4 and 7) that associate with mTOR in the even when cell lysates are prepared without the cross-
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Figure 8. Rapamycin Destabilizes the mTOR-Raptor Interaction under Leucine-Rich or -Poor Conditions
(A) mTOR immunoprecipitates isolated from HEK293T cells treated for 10 min with 10 nM rapamycin, 10 nM FK506, or ethanol or from cell
lysates treated with 10 nM rapamycin were analyzed by immunoblotting for mTOR and raptor.
(B) HEK293T cells treated with increasing concentrations of rapamycin (0, 2, 5, 10, 20, or 30 nM) for 20 min before (left) or after (middle) incubation
of cells for 30 min in leucine-free RPMI or after incubation for 30 min in leucine-rich RPMI (right). The amount of raptor coimmunoprecipitating with
mTOR was quantitated, normalized to the amount obtained in the absence of rapamycin (first lane in each group), and plotted against the
rapamycin concentration (graph).
(C) Model to explain effects of nutrients on mTOR-raptor complex and the mTOR activity.
linker. On the other hand, under nutrient-rich conditions, sterically preventing substrates from accessing the
mTOR active site. On the other hand, the constitutivethe association is weaker and most of the complex
readily falls apart in the absence of the crosslinker. interaction is clearly not required for in vitro kinase activ-
ity as we found that raptor-depleted mTOR stronglyThese findings are consistent with a model in which
mTOR and raptor are held together in a constitutive, phosphorylates S6K1. Previous studies have shown that
to function in vivo mTOR requires more than its kinaseeasily disrupted association, which, under nutrient-poor
conditions, is strengthened by an additional interac- activity because truncation and point mutants of mTOR
that retain wild-type kinase activity cannot signal to S6K1tion(s) that also lead to a repression of the kinase activity
of mTOR. Thus, we propose that at least two interactions within mammalian cells (Brown et al., 1995; Sabatini et al.,
1999). Our work suggests that raptor makes extensiveexist between raptor and mTOR: a “constitutive” interac-
tion that is required for in vivo mTOR function and a contacts with mTOR regions that are far from its kinase
domain. Thus, it is likely that in vivo the constitutive“nutrient-sensitive” interaction that forms in the ab-
sence of nutrients and leads to the inhibition of the mTOR-raptor interaction is required for a function other
than mTOR kinase activity. A simple possibility, supportedmTOR kinase activity (Figure 8C). In support of this
model, we found two raptor mutants that associate with by the finding that a reduction in raptor levels also reduces
mTOR levels, is that raptor is required for the propermTOR in ways that suggest they have selective defects
in the nutrient-sensitive interaction postulated above. folding and/or stability of mTOR. On the other hand,
raptor could also serve as an adaptor that brings sub-In addition to changes in mTOR kinase activity, other
mechanisms are also likely involved in controlling down- strates to the mTOR kinase domain and/or may be a deter-
minant of the proper subcellular localization of mTOR.stream effectors of mTOR, such as mTOR regulation of
a phosphatase(s) that inhibits S6K1.
The molecular mechanisms by which raptor regulates Rapamycin Destabilizes the NSC Irrespective
of Nutrient ConditionsmTOR are unknown. The nutrient-sensitive mTOR-rap-
tor interaction might decrease the catalytic activity of Although rapamycin and nutrient deprivation similarly
inhibit the activity of downstream components of themTOR by inducing a conformational change in the mTOR
kinase domain (mechanism shown in Figure 8C) or by mTOR pathway, such as S6K and 4E-BP1, we find that
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they have opposite effects on the mTOR-raptor interac- through other mechanisms. Perhaps growth factors reg-
ulate currently unexplored properties of raptor, suchtion. Rapamycin destabilizes the interaction regardless
of nutrient availability, and its potency for dissociation as its phosphorylation state, or signal to S6K1 through
mechanisms that do not involve this protein. As con-is increased under nutrient-rich conditions.
Several mechanisms can be proposed to account for served raptor and mTOR homologs are also found in
yeast, it is likely that the TOR pathway evolved to sensethe effects of FKBP12-rapamycin on the stability of the
complex and to explain how the drug inhibits the path- nutrient-derived signals that drive cell-autonomous
growth. Systems that respond to the polypeptide factorsway. Of the many possible models, two appealing ones
will be considered here. In the first, FKBP12-rapamycin that coordinate the growth of groups of cells found in
mammalian organs likely evolved later and became inte-dislodges raptor from its nutrient-sensitive binding site
on mTOR because it binds to mTOR at or near that grated into prior nutrient-sensing pathways in ways that
are still not understood.site. By replacing raptor at this site, FKBP12-rapamycin
would mimic raptor’s inhibitory effect on the mTOR ki- We have demonstrated that in vivo mTOR interacts
with raptor, a protein that functions positively in thenase that is manifested under nutrient-poor conditions.
A prediction of this model is that in vitro FKBP12-rapa- mTOR pathway. Under nutrient-deprived conditions,
raptor also serves as a negative regulator of mTOR ki-mycin should inhibit mTOR kinase activity, a result seen
in many studies (Brown et al., 1995; Brunn et al., 1996, nase activity. We propose that the regulation of the
mTOR-raptor interaction is a critical mechanism by1997; Burnett et al., 1998; Isotani et al., 1999). In the
second model, FKBP12-rapamycin does not affect the which eukaryotic cells coordinate the rate of cell growth
with different environmental conditions. Perhaps smallnutrient-sensitive interaction but interferes with the con-
stitutive mTOR-raptor interaction. Because this is a pos- molecules can be designed that perturb the mTOR-rap-
tor association in subtler ways than rapamycin, allowingitive interaction required for the in vivo function of
mTOR, its interference by FKBP12-rapamycin inhibits a finer pharmacological control of the TOR pathway than
is currently possible.the pathway. Of course, it is also possible that rapamycin
exerts its negative effects on the pathway independently
of its perturbation of the mTOR-raptor complex. Experimental Procedures
MaterialsDiverse Signals Converge on the Regulation
Reagents were obtained from the following sources: DSP and pro-
of the NSC tein G-sepharose from Pierce; L-[35S]methionine and [-32P]ATP from
How might changes in levels of diverse nutrients regulate NEN; mTOR, EGFR, S6K1, actin, lamin, and PI3-K antibodies and
HRP-labeled anti-mouse, anti-goat, and anti-rabbit secondary anti-the strength of the NSC association? Certainly, mTOR
bodies from Santa Cruz Biotechnology; Phospho-T389 S6K1 andand/or raptor could be phosphorylated or modified by
Phospho-S473 PKB/Akt antibodies from Cell Signaling; HA mono-upstream “nutrient sensors” that regulate their interac-
clonal antibody from Covance; myc monoclonal antibody from On-tion. We favor a hypothesis in which the mTOR-raptor
cogene Research Products; myc rabbit polyclonal antibody from
complex is itself the nutrient sensor. In this scenario, Upstate Biotechnology; eIF-4E antibody from Transduction Labora-
one or more intracellular molecules increase in concen- tories; DMEM, leucine, glucose, RPMI, and RPMI without amino
acids, leucine, or glucose from Life Technologies; and rapamycin,tration in nutrient-rich conditions and bind to raptor and/
FK506, valinomycin, antimycin A, PKI, H-8, PD98059, LY294002, andor mTOR, destabilizing the NSC and relieving raptor
2-deoxyglucose from Calbiochem. Rabbit polyclonal anti-peptideinhibition of the mTOR kinase (Figure 8C). If a single
antibodies recognizing human mTOR and raptor were producedmolecular species sufficed to destabilize the interaction,
using the regular antibody service from Zymed.
its concentration would have to reflect the availability
of both leucine and glucose, as well as the state of
Crosslinking Assay and Immunoprecipitations
mitochondrial metabolism. Alternatively, destabilization Three million HEK293T cells growing in 6 cm dishes in DMEM with
could require several molecular species that are derived 10% dialyzed fetal calf serum were metabolically labeled by the
addition of 0.4 mCi of [35S]methionine for 2 hr. Cells were rinsedfrom distinct nutrients and act on multiple independent
once with PBS, lysed in 300 l of ice-cold Buffer A (40 mM HEPESsites on the NSC. Because raptor and mTOR are large
[pH 7.5], 120 mM NaCl, 1 mM EDTA, 10 mM pyrophosphate, 10 mMproteins with high potentials for small molecule-induced
glycerophosphate, 50 mM NaF, 1.5 mM Na3VO4, 1% Triton X-100,allosteric and conformational changes that may affect pro-
and one tablet EDTA-free protease inhibitors [Roche] per 10 ml)
tein-protein interactions, the NSC appears well equipped with or without 2.5 mg/ml DSP, and incubated for 30 min on ice.
for sensing multiple growth signals. Crosslinking reactions were quenched by adding 75 l 1 M Tris-
HCl (pH 7.4) followed by an additional 30 min incubation. AfterIt is worth noting that the interaction is exquisitely
clearing, 30 l of a 50% slurry of protein G-sepharose and 4 g ofsensitive to the detergent Triton X-100. This may indi-
the anti-mTOR antibody was added to the supernatant and rotatedcate that a hydrophobic molecule, such as a lipid, plays
for 3 hr at 4C. Immunoprecipitates were washed once each witha role in maintaining the interaction, or that Triton X-100
Tris-buffered saline containing 0.05% Tween 20, Wash Buffer 1 (50
mimics a molecule that normally weakens it in vivo. mM HEPES [pH 7.5], 40 mM NaCl, and 2 mM EDTA) with 1% Triton
Consistent with this possibility, mTOR is found in associ- X-100, Wash Buffer 1 with 500 mM LiCl and 0.5% Triton X-100,
Wash Buffer 1 with 500 mM LiCl, and Wash Buffer 2 (50 mM HEPESation with membrane fractions (Sabatini et al., 1999).
[pH 7.5] and 150 mM NaCl). 5 sample buffer (0.242 M Tris, 10%Polypeptide growth factors such as insulin regulate
SDS, 25% glycerol, 0.5 M dithiothreitol, and bromophenol blue) wasS6K1 and mammalian cell growth (Efstratiadis, 1998;
added to washed immunoprecipitates and incubated for 1 hr at 37CTaha and Klip, 1999), and mTOR is considered a media-
to reduce the DSP crosslinking. Samples were resolved by 3%–8%
tor of insulin signaling (Lawrence and Brunn, 2001). SDS-PAGE, proteins were transferred to (poly(vinylidene difluoride))
However, insulin does not appear to regulate the mTOR- PVDF, and the blot was exposed to film.
In the absence of the crosslinker, cells were lysed in ice-coldraptor interaction, suggesting that it signals to S6K1
Cell
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Buffer B (Buffer A with 0.3% CHAPS instead of Triton X-100), and In Vitro Kinase Assay for mTOR Activity
Kinase assays were performed in 10 l at 30C for 20 min andmTOR immunoprecipitates were washed four times in Buffer B and
twice in Wash Buffer 2. contained 1/4 of the washed mTOR immunoprecipitates from 10
million HEK293T cells grown on a 10 cm dish, 200 ng of a GST-
S6K1 fusion protein (amino acids 332–502) or 1 g of 4E-BP1, 1 Ci
Mass Spectrometric Analysis
of [-32 P]ATP, 25 mM HEPES-KOH [pH 7.4], 50 mM KCl, 20% glyc-
mTOR immunoprecipitates prepared from 250 million HEK293T cells
erol, 10 mM MgCl2, 4 mM MnCl2, 1 mM DTT, and 50 M unlabeledwere resolved by SDS-PAGE, and the stained protein band corre-
ATP. When used, inhibitors were added 10 min prior to the start of
sponding to raptor was digested with trypsin and batch-fractionated
the kinase assay. Reactions stopped by adding 5 l of 2 sample
on a Poros 50 R2 RP micro-tip (Erdjument-Bromage et al., 1998), and
buffer were analyzed by 8% or 16% SDS-PAGE and transferred to
peptide pools were analyzed by matrix-assisted laser-desorption/
PVDF, and phosphorylated proteins were detected with autoradiog-
ionization reflectron time-of-flight (MALDI-reTOF) mass spectrometry
raphy. Kinase assays using recombinant mTOR were as described
(Geromanos et al., 2000). Selected mass values from the MALDI-TOF
(Burnett et al., 1998) except that immunoprecipitates were washed
spectra were used to search the human segment of a nonredundant
as above.
protein database (NR; NCBI, Bethesda, MD) using PeptideSearch
(Matthias Mann, University of Southern Denmark).
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